Startups
Edit
https://www.fpwr.org/
The Foundation for Prader-Willi Research
TrustedLast activity: 12.08.2026
Active
FPWR's mission is to eliminate the challenges of Prader-Willi syndrome (PWS) through the advancement
Overview
Phone
+1 888-322-5487
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 22, 2025 | A revolutionary drug for extreme hunger offers clues to obesity’s complexity | But what’s becoming clear is that obesity isn’t one disease — it’s many, said Jack Yanovski, a senior obesity researcher at the National Institutes of Health, who co-authored some of the Vykat XR studies. Researchers are learning that obesi... |
| May 4, 2023 | La Fundación para la Investigación del Síndrome de Prader-Willi otorga un préstamo convertible a Palobiofarma | 04/05/2023 Nota de prensa LA FUNDACIÓN PARA LA INVESTIGACIÓN DEL SÍNDROME DE PRADER-WILLI OTORGA UN PRÉSTAMO CONVERTIBLE A PALOBIOFARMA La Fundación para la Investigación del Síndrome de Prader-Willi (FPWR, por sus siglas en inglés) ha o... |
| Jan 18, 2022 | FDA has no appetite for Levo’s metabolic disorder drug and asks for new trial | A Levo Therapeutics drug designed to curb the insatiable hunger experienced by patients with Prader-Willi syndrome has fallen short at the FDA, as the regulator turned down the biotech’s drug application and asked for another clinical trial... |
| Jun 24, 2021 | My Gene Counsel Selected by Foundation for Prader-Willi Research to Enable Responsible Return of Results for Genome Sequencing Project | NEW HAVEN, Conn. (PRWEB) June 24, 2021 My Gene Counsel, a digital health company that provides innovative genetic counseling solutions, today announced it is partnering with the Foundation for Prader-Willi Research (FPWR) on the first Prade... |
| Feb 22, 2021 | Soleno Therapeutics : February 2021 Corporate Presentation | February 2021 | Soleno Therapeutics Corporate PresentationCertain Notices and Disclaimers Forward-Looking Statements This presentation contains forward-looking statements that are subject to many risks and uncertainties. Forward-looking sta... |
| FDA has no appetite for Levo’s metabolic disorder drug and asks for new trial | A Levo Therapeutics drug designed to curb the insatiable hunger experienced by patients with Prader-Willi syndrome has fallen short at the FDA, as the regulator turned down the biotech’s drug application and asked for another clinical trial... |
Reviews 0
FAQ about The Foundation for Prader-Willi Research
What has the press written about The Foundation for Prader-Willi Research?
Parsers VC has collected 7 articles mentioning The Foundation for Prader-Willi Research, among them “A revolutionary drug for extreme hunger offers clues to obesity’s complexity” (Jun 22, 2025) and “La Fundación para la Investigación del Síndrome de Prader-Willi otorga un préstamo convertible a Palobiofarma” (May 4, 2023).
Is The Foundation for Prader-Willi Research still active?
Yes, The Foundation for Prader-Willi Research is active; its latest activity on Parsers VC dates from Aug 12, 2026.